{"name":"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.","slug":"anhui-zhifei-longcom-biologic-pharmacy-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"Tetravalent influenza virus lysis vaccine","genericName":"Tetravalent influenza virus lysis vaccine","slug":"tetravalent-influenza-virus-lysis-vaccine","indication":"Prevention of seasonal influenza (tetravalent strains)","status":"phase_3"},{"name":"Active compared Vaccine","genericName":"Active compared Vaccine","slug":"active-compared-vaccine","indication":"Other","status":"phase_3"},{"name":"Low dose vaccine","genericName":"Low dose vaccine","slug":"low-dose-vaccine","indication":"Other","status":"phase_1"},{"name":"Vaccae","genericName":"Vaccae","slug":"vaccae","indication":"Other","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"neuroscience","drugs":[{"name":"Purified Protein Derivative of Tuberculin","genericName":"Purified Protein Derivative of Tuberculin","slug":"purified-protein-derivative-of-tuberculin","indication":"Diagnosis of tuberculosis infection","status":"phase_3"},{"name":"Recombinant Mycobacterium Tuberculosis Fusion Protein","genericName":"Recombinant Mycobacterium Tuberculosis Fusion Protein","slug":"recombinant-mycobacterium-tuberculosis-fusion-protein","indication":"Tuberculosis (active disease or latent TB infection prevention)","status":"phase_3"},{"name":"placebo of Bacillus Calmette - Guerin","genericName":"placebo of Bacillus Calmette - Guerin","slug":"placebo-of-bacillus-calmette-guerin","indication":"Severe forms of tuberculosis, such as TB meningitis and miliary TB","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"cardiovascular","drugs":[{"name":"Mycobacterium Vaccae for Injection","genericName":"Mycobacterium Vaccae for Injection","slug":"mycobacterium-vaccae-for-injection","indication":"Tuberculosis (adjunctive immunotherapy in combination with standard anti-TB chemotherapy)","status":"marketed"},{"name":"TB-PPD was injected","genericName":"TB-PPD was injected","slug":"tb-ppd-was-injected","indication":"Tuberculosis infection screening and diagnosis via intradermal skin test","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"BCG for Therapeutic Use","genericName":"BCG for Therapeutic Use","slug":"bcg-for-therapeutic-use","indication":"Non-muscle invasive bladder cancer (intravesical immunotherapy)","status":"phase_3"}]}],"pipeline":[{"name":"Tetravalent influenza virus lysis vaccine","genericName":"Tetravalent influenza virus lysis vaccine","slug":"tetravalent-influenza-virus-lysis-vaccine","phase":"phase_3","mechanism":"A tetravalent inactivated influenza vaccine that stimulates immune responses against four strains of influenza virus through viral antigen presentation.","indications":["Prevention of seasonal influenza (tetravalent strains)"],"catalyst":""},{"name":"Active compared Vaccine","genericName":"Active compared Vaccine","slug":"active-compared-vaccine","phase":"phase_3","mechanism":"This is a recombinant protein vaccine designed to stimulate immune responses against a specific pathogen or disease target.","indications":[],"catalyst":""},{"name":"BCG for Therapeutic Use","genericName":"BCG for Therapeutic Use","slug":"bcg-for-therapeutic-use","phase":"phase_3","mechanism":"BCG (Bacillus Calmette-Guérin) activates the innate and adaptive immune system to enhance anti-tumor and anti-pathogen immune responses.","indications":["Non-muscle invasive bladder cancer (intravesical immunotherapy)","Therapeutic vaccine for infectious diseases (investigational)"],"catalyst":""},{"name":"Low dose vaccine","genericName":"Low dose vaccine","slug":"low-dose-vaccine","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Mycobacterium Vaccae for Injection","genericName":"Mycobacterium Vaccae for Injection","slug":"mycobacterium-vaccae-for-injection","phase":"marketed","mechanism":"Mycobacterium vaccae is an inactivated whole-cell vaccine that stimulates the immune system to enhance Th1-mediated cellular immunity against tuberculosis and other mycobacterial infections.","indications":["Tuberculosis (adjunctive immunotherapy in combination with standard anti-TB chemotherapy)","Mycobacterial infections"],"catalyst":""},{"name":"Purified Protein Derivative of Tuberculin","genericName":"Purified Protein Derivative of Tuberculin","slug":"purified-protein-derivative-of-tuberculin","phase":"phase_3","mechanism":"Purified Protein Derivative of Tuberculin (PPD) works by stimulating a cell-mediated immune response against Mycobacterium tuberculosis.","indications":["Diagnosis of tuberculosis infection"],"catalyst":""},{"name":"Recombinant Mycobacterium Tuberculosis Fusion Protein","genericName":"Recombinant Mycobacterium Tuberculosis Fusion Protein","slug":"recombinant-mycobacterium-tuberculosis-fusion-protein","phase":"phase_3","mechanism":"This recombinant fusion protein combines multiple Mycobacterium tuberculosis antigens to stimulate cellular and humoral immune responses against tuberculosis infection.","indications":["Tuberculosis (active disease or latent TB infection prevention)"],"catalyst":""},{"name":"TB-PPD was injected","genericName":"TB-PPD was injected","slug":"tb-ppd-was-injected","phase":"marketed","mechanism":"TB-PPD is a purified protein derivative (PPD) tuberculin skin test antigen that elicits a delayed-type hypersensitivity immune response to detect tuberculosis infection or immunity.","indications":["Tuberculosis infection screening and diagnosis via intradermal skin test","Assessment of tuberculosis immunity and vaccine response"],"catalyst":""},{"name":"Vaccae","genericName":"Vaccae","slug":"vaccae","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"placebo of Bacillus Calmette - Guerin","genericName":"placebo of Bacillus Calmette - Guerin","slug":"placebo-of-bacillus-calmette-guerin","phase":"phase_3","mechanism":"The Bacillus Calmette-Guérin (BCG) vaccine is a live attenuated vaccine that stimulates a cell-mediated immune response against Mycobacterium tuberculosis.","indications":["Severe forms of tuberculosis, such as TB meningitis and miliary TB"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQbVg5dmk4NkpoampYTlRvRTJHRm9xZHVaQkdGVzNJWl9yUmlHSEZNTVRmU2lTbmFMU2tqNDR6WWc0WGlpdGdMNWJfeWg4TTdMdFdDdWIyQkdYOVBQUDNUWThjc2FkQ0hzcm0wOVZ4bjN0a2wtVWtvaTBrWlJvYVNhajF6TDFsTGZNTHJMVVlaZDVmOXlpUnc?oc=5","date":"2025-01-11","type":"pipeline","source":"fortune.com","summary":"Moderna says it’s ‘one step closer’ to a norovirus vaccine as the virus spreads across the U.S. - fortune.com","headline":"Moderna says it’s ‘one step closer’ to a norovirus vaccine as the virus spreads across the U.S.","sentiment":"neutral"}],"patents":[],"drugCount":10,"phaseCounts":{"phase_3":7,"phase_1":1,"marketed":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}